Regulatory Demand CeeTox provides a suite of in vitro safety tests that replace animal testing, aligning with global regulatory trends such as REACH and the Cosmetics Directive, creating a compelling sales angle for cosmetics, chemical, and pharma clients seeking compliant non-animal solutions.

Comprehensive Panel The breadth of end points, including skin irritation and corrosion, percutaneous absorption, phototoxicity, ocular effects, skin sensitization, endocrine disruption, and acute toxicity, enables a one-stop safety assessment and potential cost and time efficiencies for clients.

Industry Focus Serving pharma, fragrance, personal care, cosmetics, chemical, and cleaning product sectors, CeeTox can tailor offerings to multiple high-regulatory verticals and create multiple cross-sell opportunities within existing client bases.

Strategic Synergy As part of the Cyprotex ADME-Tox ecosystem since the acquisition, CeeTox can tap into a broader network to cross-sell integrated safety screening with ADME-Tox services to existing Cyprotex customers and prospects.

Client-Centric Agility A small, team-oriented CRO model supports rapid study setup, customized project counseling, and close collaboration with R&D teams, which can drive higher win rates in competitive biotech and pharma R&D environments.